Academic literature on the topic 'Rocky Mountain spotted fever. Rocky Mountain spotted fever tick'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Rocky Mountain spotted fever. Rocky Mountain spotted fever tick.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Rocky Mountain spotted fever. Rocky Mountain spotted fever tick"
Phillips, Jennan. "Rocky Mountain Spotted Fever." Workplace Health & Safety 65, no. 1 (January 2017): 48. http://dx.doi.org/10.1177/2165079916683711.
Full textMcFee, Robin B. "Tick borne illness - Rocky mountain spotted fever." Disease-a-Month 64, no. 5 (May 2018): 185–94. http://dx.doi.org/10.1016/j.disamonth.2018.01.006.
Full textRhodes, Steven D., Alicia M. Teagarden, Brian Graner, Riad Lutfi, and Chandy C. John. "Brain Death Secondary to Rocky Mountain Spotted Fever Encephalitis." Case Reports in Critical Care 2020 (May 4, 2020): 1–5. http://dx.doi.org/10.1155/2020/5329420.
Full textBradshaw, Michael J., Kelly Carpenter Byrge, Kelsey S. Ivey, Sumit Pruthi, and Karen C. Bloch. "Meningoencephalitis due to Spotted Fever Rickettsioses, Including Rocky Mountain Spotted Fever." Clinical Infectious Diseases 71, no. 1 (August 15, 2019): 188–95. http://dx.doi.org/10.1093/cid/ciz776.
Full textTribaldos, Maribel, Yamitzel Zaldivar, Sergio Bermudez, Franklyn Samudio, Yaxelis Mendoza, Alexander A. Martinez, Rodrigo Villalobos, et al. "Rocky Mountain spotted fever in Panama: a cluster description." Journal of Infection in Developing Countries 5, no. 10 (August 29, 2011): 737–41. http://dx.doi.org/10.3855/jidc.2189.
Full textMahto, Subodh K., Pulin K. Gupta, Sahil Sareen, Arjun M. Balakrishnaa, and Sumit K. Suman. "A case of rocky mountain spotted fever without eschar as a cause of pyrexia with multiple organ failure." International Journal of Research in Medical Sciences 5, no. 10 (September 28, 2017): 4658. http://dx.doi.org/10.18203/2320-6012.ijrms20174618.
Full textBaldeo, Cherisse, Karan Seegobin, and Lara Zuberi. "Immune Thrombocytopenia as a Consequence of Rocky Mountain Spotted Fever." Case Reports in Oncology 10, no. 3 (October 23, 2017): 945–47. http://dx.doi.org/10.1159/000481617.
Full textNett, Randall J., Earl Book, and Alicia D. Anderson. "Q Fever with Unusual Exposure History: A Classic Presentation of a Commonly Misdiagnosed Disease." Case Reports in Infectious Diseases 2012 (2012): 1–3. http://dx.doi.org/10.1155/2012/916142.
Full textWalker, D. H. "Rocky Mountain spotted fever: a disease in need of microbiological concern." Clinical Microbiology Reviews 2, no. 3 (July 1989): 227–40. http://dx.doi.org/10.1128/cmr.2.3.227.
Full textStockman, J. A. "Rocky Mountain Spotted Fever From an Unexpected Tick Vector in Arizona." Yearbook of Pediatrics 2007 (January 2007): 33–34. http://dx.doi.org/10.1016/s0084-3954(08)70020-4.
Full textDissertations / Theses on the topic "Rocky Mountain spotted fever. Rocky Mountain spotted fever tick"
Abley, Melanie J. "The detection and distrubution [i.e. distribution] of a Rocky Mountain spotted fever group Rickettsia sp. and Babesia microti from Ixodes scapularis in Indiana counties." Virtual Press, 2004. http://liblink.bsu.edu/uhtbin/catkey/1306387.
Full textDepartment of Physiology and Health Science
Angerami, Rodrigo Nogueira. "Febre maculosa brasileira no estado de São Paulo = aspectos clínicos e epidemiológicos." [s.n.], 2011. http://repositorio.unicamp.br/jspui/handle/REPOSIP/310588.
Full textTese (doutorado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas
Made available in DSpace on 2018-08-18T15:04:22Z (GMT). No. of bitstreams: 1 Angerami_RodrigoNogueira_D.pdf: 7670692 bytes, checksum: f6634d52b90eaf383ed11a180b9179aa (MD5) Previous issue date: 2011
Resumo: Causada pela bactéria Rickettsia rickettsii e transmitida pelos carrapatos Amblyomma cajennense e Amblyomma aureolatum, a febre maculosa brasileira (FMB), após décadas de aparente silêncio epidemiológico, desde sua reemergência nos anos 80, vem figurando como importante problema de saúde pública no estado de São Paulo, sobretudo, em decorrência da aparente expansão das áreas de transmissão e da elevada letalidade a ela associada. O objetivo principal do presente estudo foi descrever características clínicas e epidemiológicas da FMB a partir da análise retrospectiva de casos confirmados da doença em áreas endêmicas no estado de São Paulo. Foi observado que manifestações inespecíficas como febre, cefaléia, mialgia e exantema, foram os sinais clínicos mais freqüentes e precoces. Embora variáveis, elevadas frequências de fenômenos hemorrágicos (22,9%-77,6%), icterícia (16,7%-52%), alterações neurológicas (27,2%-51,7%) e insuficiência respiratória (17,5%-62%) foram observadas. A taxa de letalidade média no estado de São Paulo no período de 2003 a 2008 foi de 29,6%(21,9%-40%). Trombocitopenia e elevação de transaminases hepáticas foram as alterações laboratoriais mais frequentes, ocorrendo em até 100% dos casos. Na faixa etária pediátrica, a FMB também se apresentou como doença severa, associando-se, embora em menor freqüência, às complicações acima mencionadas e à elevada letalidade (28,4%). Entretanto, em estudo comparativo entre o perfil clínico da FMB nos estados de São Paulo e Santa Catarina, observou-se no estado do Sul uma doença com evolução benigna, pequena frequência de sinais de gravidade e ausência de óbitos. Entre pacientes com FMB, as síndromes febris hemorrágica, icterohemorrágica e exantemática foram as mais comumente observadas (37,1%, 33,9%, 11,3%, respectivamente). Dentre os principais diagnósticos diferenciais da FMB, leptospirose, dengue e doença meningocócica foram as mais prevalentes (28,5%, 17,2%, 5,4%, respectivamente). Em 31% dos casos descartados para FMB não foi possível a identificação do diagnóstico etiológico. A doença foi mais incidente no gênero masculino e entre indivíduos da faixa etária de 20 a 49 anos. Em áreas em que o A. cajennense é o principal vetor foi possível observar maior incidência da doença entre o período de Junho a Setembro. Surtos de FMB se associaram a elevadas taxas de letalidade e a diferentes determinantes ecoepidemiológicos. Atividades de lazer e ocupacionais em áreas de mata, pastagem, próximas a coleções hídricas e/ou com presença de animais (cavalos, capivaras e, eventualmente, cães) foram consideradas importantes exposições de risco para infecção. O presente estudo permitiu observar que a infecção pela R. rickettsii no estado de São Paulo se associa à elevada morbimortalidade, sendo, aparentemente, mais severa que a febre das Montanhas Rochosas nos Estados Unidos. Exantema, icterícia e hemorragias são importantes marcadores clínicos que devem ser considerados na suspeição da doença e seus diagnósticos diferencias. O conhecimento das características epidemiológicas e dos fatores de risco para infecção deve fundamentar as ações de prevenção e controle da FMB. A maior severidade da infecção pela R. rickettsii no estado de São Paulo, a ocorrência de casos atípicos em Santa Catarina e a ausência de elucidação diagnóstica em casos descartados para FMB sugerem que cepas de R. rickettsii com distintos padrões de virulência, bem como outras espécies de riquétsias e, eventualmente, outros microorganismos transmitidos por carrapatos devam estar ocorrendo no Brasil
Abstract: Brazilian spotted fever (BSF) is caused by Rickettsia rickettsii and transmited by Amblyomma cajennense and Amblyomma aureolatum ticks. After decades of an apparent epidemiological silence, BSF reemerged as an important public health problem in São Paulo State in the 1980's, mostly because the possible expansion of its transmission areas and the high BSF related fatality-rate. The main objective of the present study was to describe clinical and epidemiological features of BSF through a retrospective analysis of BSF confirmed cases in endemic areas. Non-specific clinical signs like fever, myalgia, headache, and exanthema were the earliest and most frequent clinical signs. A high frequency of hemorrhagic manifestations (22.9%-77.6%), icterus (16.7%-52%), neurological signs (27.2%-51.7%), and respiratory distress (17.5%-62%) was also observed. Case-fatality ratio in São Paulo State between 2003 and 2008 was 29.6% (21.9%-40%). Thrombocytopenia and elevated liver enzymes were the most frequent laboratorial abnormalities, reaching 100% in some groups. In the pediatric age-group, BSF also presented as a severe disease with a slightly lower rate of clinical complications, but a similar high lethality rate (28.4%). Interestingly, when we compared the clinical profile of BSF cases between São Paulo state and Santa Catarina state, located in the southernmost part of Brazil, a milder disease, with a lower frequency of clinical signs of severity and no fatalities was observed in the latter. The most frequent clinical syndromes occurring in BSF patients were hemorrhagic, ictero-hemorrhagic, and exanthematic acute febrile syndromes (37.1%, 33.9% and 11.3% respectively). The most important differential diagnosis to BSF was leptospirosis, dengue fever, and meningococcal disease (28.5%, 17.2%, and 5.4%, respectively). In 31% of non-confirmed BSF cases, no etiological diagnosis was defined. A higher incidence of BSF was observed in males and in the 20-49 years age-group. In areas where A. cajennense is recognized as the most important vector, a higher BSF incidence was observed from June to September. Clusters of BSF were associated to elevated fatality rates and a wide number of ecoepidemiological determinants. Recreational and occupational activities in rural, periurban, and waterside areas, with presence of animals (mostly horses and capybaras, and eventually dogs) were considered the most important exposure risk factors to infection. The present study suggests a more severe pattern of R. rickettsii in São Paulo state when compared with Rocky Mountain spotted fever in United States. Exanthema, icterus, and hemorrhage are important clinical markers of BSF and should be considered in the suspicion of this disease and as a differential diagnosis. Knowledge of clinical, epidemiological, and risk factors for infection should be used to structure and improve the measures for control and prevention of BSF. Together, the higher severity of R. rickettsii infection in São Paulo state, the occurrence of atypical cases in Santa Catarina, and the unknown etiological diagnosis of a high percentage of post-tick exposure febrile patients suggest that more virulent R. rickettsii strains, other Rickttsiae species and, eventually, other tick-borne diseases could be occurring in Brazil
Doutorado
Clinica Medica
Doutor em Clínica Médica
Books on the topic "Rocky Mountain spotted fever. Rocky Mountain spotted fever tick"
Rocky Mountain spotted fever: History of a twentieth-century disease. Baltimore: Johns Hopkins University Press, 1990.
Find full textFletcher, Tom, and Nick Beeching. Rickettsial infection. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0314.
Full textSun, Lisa, and Michael V. Johnston. Rickettsial Diseases. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199937837.003.0157.
Full textNational Institute of Allergy and Infectious Diseases (U.S.). Office of Research Reporting and Public Response, ed. Rocky Mountain spotted fever. Bethesda, Md: The Office, 1985.
Find full textNational Institutes of Health (U.S.), ed. Rocky Mountain spotted fever. Bethesda, Md: National Institutes of Health, 1987.
Find full textNews, PM Medical Health. 21st Century Complete Medical Guide to Rocky Mountain Spotted Fever (RMSF) and Related Tick Bite Diseases, Authoritative Government Documents, Clinical ... for Patients and Physicians (CD-ROM). Progressive Management, 2004.
Find full textCuttle, Lisa. Dermatologic Manifestations of Infectious Disease. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199976805.003.0044.
Full textBurdmann, Emmanuel A., and Vivekanad Jha. Rickettsiosis. Edited by Vivekanand Jha. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199592548.003.0193.
Full textTuddenham, Susan. Ehrlichia, Anaplasma, and Rickettsia. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199976805.003.0051.
Full textBook chapters on the topic "Rocky Mountain spotted fever. Rocky Mountain spotted fever tick"
Macaluso, Kevin R., and Abdu F. Azad. "Rocky Mountain Spotted Fever and Other Spotted Fever Group Rickettsioses." In Tick-Borne Diseases of Humans, 292–301. Washington, DC, USA: ASM Press, 2014. http://dx.doi.org/10.1128/9781555816490.ch17.
Full textTreadwell, Patricia. "Rocky Mountain Spotted Fever." In Atlas of Adolescent Dermatology, 37–39. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-58634-8_9.
Full textMilstone, Aaron, and J. Stephen Dumler. "Rocky Mountain Spotted Fever." In Bacterial Infections of Humans, 661–76. Boston, MA: Springer US, 2009. http://dx.doi.org/10.1007/978-0-387-09843-2_31.
Full textGooch, Jan W. "Rocky Mountain Spotted Fever." In Encyclopedic Dictionary of Polymers, 921. New York, NY: Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4419-6247-8_14722.
Full textWoodward, Theodore E. "Rocky Mountain Spotted Fever." In Bacterial Infections of Humans, 561–72. Boston, MA: Springer US, 1991. http://dx.doi.org/10.1007/978-1-4757-1211-7_27.
Full textKubala, Ginger S. "Rocky Mountain Spotted Fever." In Family Medicine, 316–21. New York, NY: Springer New York, 1994. http://dx.doi.org/10.1007/978-1-4757-4005-9_40.
Full textLeppla, Norman C., Bastiaan M. Drees, Allan T. Showler, John L. Capinera, Jorge E. Peña, Catharine M. Mannion, F. William Howard, et al. "Rocky Mountain Spotted Fever." In Encyclopedia of Entomology, 3202–6. Dordrecht: Springer Netherlands, 2008. http://dx.doi.org/10.1007/978-1-4020-6359-6_3426.
Full textWoodward, Theodore E., and J. Stephen Dumler. "Rocky Mountain Spotted Fever." In Bacterial Infections of Humans, 597–612. Boston, MA: Springer US, 1998. http://dx.doi.org/10.1007/978-1-4615-5327-4_31.
Full textGarone, Michael, and Michael B. Morgan. "Rocky Mountain Spotted Fever and Rickettsioses." In Deadly Dermatologic Diseases, 189–93. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-31566-9_31.
Full textNoor, Asif, Amy B. Triche, and Leonard R. Krilov. "Rocky Mountain Spotted Fever and Other Rickettsioses." In Introduction to Clinical Infectious Diseases, 355–64. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-91080-2_33.
Full textConference papers on the topic "Rocky Mountain spotted fever. Rocky Mountain spotted fever tick"
Nicholson, William. "Ecology and epidemiology of Rocky Mountain spotted fever associated withRhipicephalus sanguineus." In 2016 International Congress of Entomology. Entomological Society of America, 2016. http://dx.doi.org/10.1603/ice.2016.107743.
Full textVan Hook, C. J., C. McGinley, B. Warner, B. Delgado, and R. Loredo. "Fulminant Meningoencephalitis Complicating Rocky Mountain Spotted Fever in a Previously Healthy Young Adult." In American Thoracic Society 2021 International Conference, May 14-19, 2021 - San Diego, CA. American Thoracic Society, 2021. http://dx.doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a2959.
Full text